Loading insider details...
Latest Form 4 (Sep 1, 2026): Disposition to Issuer of 58,286 CRNX shares, $4.95M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 58,286 | $4.95M |
| Mar 18, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 6,371 | $236.4K |
| Feb 25, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 30,000 | n/a |
| Dec 29, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 18,000 | $34.4K |
| Jun 16, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 71,525 | $136.6K |
| Mar 21, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 5,479 | $187.2K |
| Feb 24, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 43,000 | n/a |
| Dec 18, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Exercise/Conversion | 2,331 | $4.5K |
| Sep 12, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 1,035 | $53.3K |
| Aug 28, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 3,000 | $159.6K |